Assessment of glutamate-opiate interactions: A contribution to the pathophysiology of schizophrenia?

被引：0
|
作者：
Madonick, SH
D'Souza, DC
Brush, L
Cassello, K
Sernyak, MJ
Belger, A
Krystal, JH
机构：
[1] Yale Univ, Sch Med, Dept Psychiat, W Haven, CT 06516 USA
[2] VA Connecticut, Psychiat Serv, W Haven, CT 06516 USA
来源：
SCHIZOPHRENIA RESEARCH | 1999年 / 36卷 / 1-3期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：310 / 311
页数：2
相关论文
共 50 条
  • [21] GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders
    Nicoletti, Ferdinando
    Di Menna, Luisa
    Iacovelli, Luisa
    Orlando, Rosamaria
    Zuena, Anna Rita
    Conn, P. Jeffrey
    Dogra, Shalini
    Joffe, Max E.
    NEUROPHARMACOLOGY, 2023, 235
  • [22] Metabolic Syndrome and Psychiatric Illness: Interactions, Pathophysiology, Assessment and Treatment
    Wise, Thomas N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (01) : 146 - 147
  • [23] Metabolic syndrome and psychiatric illness: Interactions, pathophysiology, assessment, and treatment
    De Leon, Jose
    AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (08): : 1056 - 1057
  • [24] GLUTAMATE AND NICOTINIC RECEPTOR INTERACTIONS IN WORKING MEMORY: IMPORTANCE FOR THE COGNITIVE IMPAIRMENT OF SCHIZOPHRENIA
    Timofeeva, O. A.
    Levin, E. D.
    NEUROSCIENCE, 2011, 195 : 21 - 36
  • [25] Glutamate-Dopamine Interactions in a Maternal Immune Activation Model with Relevance to Schizophrenia
    Bronson, Stefanie L.
    Ahlbrand, Rebecca
    Horn, Paul S.
    Kern, Joseph R.
    Richtand, Neil M.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 69S - 69S
  • [26] GLUTAMATE-DOPAMINE INTERACTIONS IN SCHIZOPHRENIA: INSIGHT FROM MOLECULAR IMAGING STUDIES
    Laruelle, Marc
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S53 - S53
  • [27] Editorial: Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathways, volume II
    Matosin, Natalie
    Nithianantharajah, Jess
    Dean, Brian
    Deng, Chao
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [28] Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine-glutamate interactions
    Brunstein, MG
    Belmonte-de-Abreu, P
    Souza, DO
    Lara, DR
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (02) : 155 - 156
  • [29] Dopamine-Glutamate Interactions: A Neural Convergence Mechanism of Common Schizophrenia Risk Variants
    Tost, Heike
    Meyer-Lindenberg, Andreas
    BIOLOGICAL PSYCHIATRY, 2011, 69 (10) : 912 - 913
  • [30] In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology
    Agrawal, Rimjhim
    Kalmady, Sunil Vasu
    Venkatasubramanian, Ganesan
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (02) : 115 - 125
12345